Mark D Fromer, MD PC

Mark D Fromer, MD PC was paid $13.39M by Medicaid between Jan 2018 and Dec 2024, across 65 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 13% of everything it billed.

33Billing provider infoMARK D FROMER, MD PC
FOREST HILLS, NY 11375

33aNPI1649306218assigned 02/26/2007

33bProvider typeOphthalmology Physician

28Total paid$13.39M

24GClaims334,007

24DCodes billed65

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Ophthalmology Physician providers in New York

Rank by total paid#2 of 1,085

Median peer was paid$34K

This provider vs. median396×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	40,795	$2.11M
2019	52,831	$2.53M
2020	41,393	$1.61M
2021	61,620	$2.21M
2022	56,408	$2.07M
2023	52,235	$1.79M
2024incomplete	28,725	$1.06M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	13%	23,351	23,272	$1.81M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	11%	26,038	25,357	$1.48M
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	9.0%	10,320	10,314	$1.21M
92083		8.6%	26,210	26,130	$1.16M
92014	Ophthalmological services: medical examination and evaluation, comprehensive, established patient	7.1%	15,069	15,014	$951K
92012	Ophthalmological services: medical examination and evaluation, intermediate, established patient	5.1%	11,751	11,503	$685K
92004	Ophthalmological services: medical examination and evaluation, comprehensive, new patient	3.8%	7,512	7,482	$504K
92226		3.3%	17,090	12,616	$441K
92134		3.2%	16,879	16,782	$431K
92202		3.1%	41,781	40,998	$416K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	3.1%	4,735	4,734	$411K
92133		2.9%	15,211	15,193	$393K

53 more codes

93886		2.7%	2,571	$355K
93890		2.4%	2,558	$326K
92225		2.4%	11,539	$323K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	2.2%	8,087	$301K
93892		1.8%	2,563	$246K
92020		1.8%	13,951	$237K
V2500	Contact lens, pmma, spherical, per lens	1.6%	345	$220K
67028	Intravitreal injection of a pharmacologic agent	1.3%	2,055	$169K
V2100	Sphere, single vision, plano to plus or minus 4.00, per lens	1.1%	9,267	$147K
92250		<1%	3,084	$127K
V2020	Frames, purchases	<1%	8,326	$118K
68761		<1%	1,873	$109K
92060		<1%	2,345	$104K
92015	Determination of refractive state	<1%	17,508	$103K
J9035	Injection, bevacizumab, 10 mg	<1%	1,562	$93K
92002		<1%	1,410	$78K
92285		<1%	3,689	$74K
66761		<1%	262	$67K
00142		<1%	669	$46K
V2200	Sphere, bifocal, plano to plus or minus 4.00d, per lens	<1%	1,662	$34K
92145		<1%	3,206	$28K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	85	$25K
76514		<1%	2,659	$24K
92201		<1%	1,148	$18K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	609	$17K
V2103	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	<1%	1,321	$13K
S0580	Polycarbonate lens (list this code in addition to the basic code for the lens)	<1%	872	$12K
92273		<1%	133	$11K
V2784	Lens, polycarbonate or equal, any index, per lens	<1%	7,859	$10K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	103	$8K
92286		<1%	279	$8K
92136		<1%	239	$7K
65855		<1%	29	$6K
76512		<1%	116	$6K
93000		<1%	448	$5K
92340	Fitting of spectacles, except for aphakia; monofocal	<1%	307	$4K
67210		<1%	13	$4K
00103		<1%	38	$4K
92025		<1%	142	$4K
83861		<1%	309	$3K
99215	Doctor's office visit, returning patient (complex)	<1%	26	$2K
92235		<1%	32	$2K
99072		<1%	994	$2K
68200		<1%	29	$647.63
99441		<1%	25	$630.61
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	<1%	106	$514.44
36415	Collection of venous blood by venipuncture	<1%	378	$160.59
99421		<1%	12	$119.79
V2104	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens	<1%	16	$97.20
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	14	$71.18
V2755	U-v lens, per lens	0%	1,124	$0.00
99000		0%	16	$0.00
A4262	Temporary, absorbable lacrimal duct implant, each	0%	47	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFROMER, MARK (PRESIDENT-CEO)

Same official

Other billing entities under FROMER, MARK

Full network →

Provider	Location	Paid
Mark Fromer, LLC	Bronx, NY	$1.94M
Mark Fromer, MD PC	New York, NY	$116K
Mark Fromer, MD PC	Bronx, NY	$52K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.